Pledge to Africa Act
| Act of Parliament | |
Long title | An Act to amend the Patent Act and the Food and Drugs Act (The Jean Chrétien Pledge to Africa |
|---|---|
The Pledge to Africa Act is an
Purpose
The purpose of the Act is to improve access to drugs for developing countries that lack the resources to manufacture the drugs and cannot afford to buy them at the usual market cost.[1] The drugs that fight these diseases are expensive to create and manufacture and thus are usually unaffordable for those who need them the most.[2]
The Pledge to Africa Act allows for the patents on these drugs to be overridden so that manufacturers can produce generic versions of the drug to sell in underdeveloped countries.[1]
Criticisms
Some questions have been raised concerning the Act's efficacy, or lack thereof, at increasing the availability of pharmaceuticals in poor nations.
References and notes
- ^ a b "Archived copy" (PDF). Archived from the original (PDF) on 2007-01-07. Retrieved 2008-07-25.
{{cite web}}: CS1 maint: archived copy as title (link) - ^ The Jean Chrétien Pledge to Africa Act: Patent Law and Humanitarian Aid
- ^ a b c ipilogue » Blog Archive » Is Canada Delivering on its Pledge to Aid Africa?
- ^ Access to Drugs Initiative – History Archived 2008-08-03 at the Wayback Machine
- ^ "Archived copy" (PDF). Archived from the original (PDF) on 2007-12-13. Retrieved 2008-07-25.
{{cite web}}: CS1 maint: archived copy as title (link)
See also
External links
- http://www2.parl.gc.ca/HousePublications/Publication.aspx?Docid=2331620&file=4 — the full text of the Bill
- http://www.camr-rcam.gc.ca/ — the Canadian government site for the Regime
- http://www.aidslaw.ca/camr/
- https://web.archive.org/web/20070209020526/http://www.law.utoronto.ca/accesstodrugs/
- http://www.cptech.org/ip/health/c/canada/c9.html